Literature DB >> 17478154

Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm.

Emmanuel I Skalidis1, Evangelos A Zacharis, Dimitrios K Tsetis, Kostas Pagonidis, Gregory Chlouverakis, Spyridon Yarmenitis, Michalis Hamilos, Emmanuel G Manios, Panos E Vardas.   

Abstract

Beat-to-beat variation in blood flow dynamics during atrial fibrillation (AF) has been associated with evidence of endothelial dysfunction. The aim of the present work is to confirm endothelial dysfunction in patients with AF and test the hypothesis that endothelial dysfunction is reversible upon restoration of normal sinus rhythm. Endothelium-dependent (flow-mediated dilation [FMD]) and endothelium-independent (nitroglycerin-mediated dilation [NMD]) vasodilator function of the brachial artery were measured using high-resolution ultrasound in 46 patients with persistent AF who were scheduled for internal electrical cardioversion and in 25 control subjects. In patients who remained in sinus rhythm after cardioversion, these measurements were repeated after 24 hours (n = 32) and 1 month (n = 19). Compared with control subjects, patients (n = 32) showed lower FMD during AF (8.1 +/- 3.6% vs 12.2 +/- 3.2%, respectively, p <0.001) and similar NMD (17.0 +/- 3.5% vs 15.9 +/- 3.1%, respectively, p = 0.21). In 19 patients who remained in sinus rhythm, FMD increased at both 24 hours (8.0 +/- 3.9% vs 10.6 +/- 4.6%, p = 0.015) and 1 month (8.0 +/- 3.9% vs 13.6 +/- 5.3%, p <0.001). In contrast, NMD was not significantly altered at 24 hours or 1 month after sinus rhythm restoration (17.1 +/- 3.9% vs 17.2 +/- 4.0% vs 16.9 +/- 4.1%). In conclusion, AF is associated with impairment in endothelial function that improves after sinus rhythm restoration.

Entities:  

Mesh:

Year:  2007        PMID: 17478154     DOI: 10.1016/j.amjcard.2006.12.044

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  23 in total

1.  Brachial flow-mediated dilation and incident atrial fibrillation: the multi-ethnic study of atherosclerosis.

Authors:  Wesley T O'Neal; Jimmy T Efird; Joseph Yeboah; Saman Nazarian; Alvaro Alonso; Susan R Heckbert; Elsayed Z Soliman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-10-23       Impact factor: 8.311

Review 2.  Peripheral artery disease and atrial fibrillation: a potentially dangerous combination.

Authors:  Francesco Violi; Gregory Y H Lip; Stefania Basili
Journal:  Intern Emerg Med       Date:  2011-06-11       Impact factor: 3.397

Review 3.  Stroke and Death Prediction with the Impact of Vascular Disease in Patients with Atrial Fibrillation.

Authors:  Abhishek Maan; Amir Y Shaikh; Moussa Mansour; Jeremy N Ruskin; E Kevin Heist
Journal:  J Atr Fibrillation       Date:  2012-06-15

4.  Association of genetic variants with atrial fibrillation.

Authors:  Yuichiro Yamase; Kimihiko Kato; Hideki Horibe; Chikara Ueyama; Tetsuo Fujimaki; Mitsutoshi Oguri; Masazumi Arai; Sachiro Watanabe; Toyoaki Murohara; Yoshiji Yamada
Journal:  Biomed Rep       Date:  2015-12-02

5.  Asymmetric dimethylarginine concentration and recurrence of atrial tachyarrythmias after catheter ablation in patients with persistent atrial fibrillation.

Authors:  Li Yang; Qu Xiufen; Sun Shuqin; Yu Yang; Song Ying; Yu Yanwei; Feng Wei; Yin Dechun
Journal:  J Interv Card Electrophysiol       Date:  2011-05-19       Impact factor: 1.900

6.  Better prediction of stroke in atrial fibrillation with incorporation of cancer in CHA2DS2VASC score: CCHA2DS2VASC score.

Authors:  Brandon Bungo; Pulkit Chaudhury; Michael Arustamyan; Rishi Rikhi; Muzna Hussain; Patrick Collier; Mohamed Kanj; Alok A Khorana; Amgad Mentias; Rohit Moudgil
Journal:  Int J Cardiol Heart Vasc       Date:  2022-06-20

7.  Atrial Fibrillation and Risk of ST-Segment-Elevation Versus Non-ST-Segment-Elevation Myocardial Infarction: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Elsayed Z Soliman; Faye Lopez; Wesley T O'Neal; Lin Y Chen; Lindsay Bengtson; Zhu-Ming Zhang; Laura Loehr; Mary Cushman; Alvaro Alonso
Journal:  Circulation       Date:  2015-04-27       Impact factor: 29.690

Review 8.  Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance.

Authors:  Irene Savelieva; Antonios Kourliouros; John Camm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-25       Impact factor: 3.000

9.  Atrial fibrillation and the risk of myocardial infarction.

Authors:  Elsayed Z Soliman; Monika M Safford; Paul Muntner; Yulia Khodneva; Farah Z Dawood; Neil A Zakai; Evan L Thacker; Suzanne Judd; Virginia J Howard; George Howard; David M Herrington; Mary Cushman
Journal:  JAMA Intern Med       Date:  2014-01       Impact factor: 21.873

10.  Current Evidence and Recommendations for Rate Control in Atrial Fibrillation.

Authors:  Abhishek Maan; Moussa Mansour; Jeremy N Ruskin; E Kevin Heist
Journal:  Arrhythm Electrophysiol Rev       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.